Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TP53 | P04637 | 7/20 | 1.00 |
| ▸ | RAB9A | P51151 | 4/20 | 1.00 |
| ▸ | CYP2C19 | P33261 | 2/20 | 1.00 |
| ▸ | ATP1A1 | P05023 | 7/20 | 0.74 |
| ▸ | ATP1B1 | P05026 | 7/20 | 0.74 |
| ▸ | ATP1A3 | P13637 | 7/20 | 0.74 |
| ▸ | ATP1B2 | P14415 | 7/20 | 0.74 |
| ▸ | ATP1A2 | P50993 | 7/20 | 0.74 |
| ▸ | ATP1B3 | P54709 | 7/20 | 0.74 |
| ▸ | FXYD2 | P54710 | 7/20 | 0.74 |
| ▸ | ATP1A4 | Q13733 | 7/20 | 0.74 |
| ▸ | SMN1; SMN2 | Q16637 | 4/20 | 0.74 |
| ▸ | PAX8 | Q06710 | 3/20 | 0.74 |
| ▸ | LMNA | P02545 | 3/20 | 0.74 |
| ▸ | NPC1 | O15118 | 3/20 | 0.74 |
| ▸ | HIF1A | Q16665 | 2/20 | 0.74 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.74 |
| ▸ | TSHR | P16473 | 1/20 | 0.74 |
| ▸ | ATP12A | P54707 | 1/20 | 0.74 |
| ▸ | SLCO4C1 | Q6ZQN7 | 2/20 | 0.62 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Gitoxigenin SCHEMBL3302691 | 1.00 | TP53 (1.00) | TP53RAB9ACYP2C19ATP1A1ATP1B1 | |
| Gitoxigenin SCHEMBL13338042 | 1.00 | TP53 (1.00) | TP53RAB9ACYP2C19ATP1A1ATP1B1 | |
| Gitoxigenin SCHEMBL19638184 | 1.00 | TP53 (1.00) | TP53RAB9ACYP2C19ATP1A1ATP1B1 | |
| Gitoxigenin SCHEMBL8417147 | 1.00 | TP53 (1.00) | TP53RAB9ACYP2C19ATP1A1ATP1B1 | |
| Gitoxigenin SCHEMBL3302694 | 1.00 | TP53 (1.00) | TP53RAB9ACYP2C19ATP1A1ATP1B1 | |
| SCHEMBL14681100 | 0.88 | TP53 (0.79) | TP53RAB9ACYP2C19ATP1A1ATP1B1 | |
| SCHEMBL4905625 | 0.88 | TP53 (0.84) | TP53RAB9ACYP2C19ATP1A1ATP1B1 | |
| SCHEMBL17864015 | 0.88 | TP53 (0.84) | TP53RAB9ACYP2C19ATP1A1ATP1B1 | |
| SCHEMBL11408235 | 0.87 | TP53 (0.77) | TP53RAB9ACYP2C19ATP1A1ATP1B1 | |
| SCHEMBL21578190 | 0.87 | TP53 (0.77) | TP53RAB9ACYP2C19ATP1A1ATP1B1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 439 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2024259191-A2 | METHOD AND COMPOSITIONS FOR TREATING SKIN DISORDERS | PHOENIX BIOTECHNOLOGY, INC. (US) | 2024-12-19 | — | — | WO | claimed |
| US-12097234-B2 | Extract containing oleandrin and method of production thereof | PHOENIX BIOTECHNOLOGY, INC. (US) | 2024-09-24 | — | — | US | claimed |
| US-20240261312-A1 | Method and compositions for treating animal viral infections | PHOENIX BIOTECHNOLOGY, INC. (US) | 2024-08-08 | — | — | US | claimed |
| EP-4387627-A1 | METHOD AND COMPOSITIONS FOR TREATING ANIMAL VIRAL INFECTIONS | Phoenix Biotechnology, Inc. (US) | 2024-06-26 | — | — | EP | claimed |
| EP-4295854-A2 | METHOD AND COMPOSITIONS FOR TREATING CORONAVIRUS INFECTION | Phoenix Biotechnology, Inc. (US) | 2023-12-27 | — | — | EP | claimed |
| WO-2023239747-A2 | METHODS OF MODULATING ATXN2 EXPRESSION | UNIVERSITY OF UTAH RESEARCH FOUNDATION (US) | 2023-12-14 | — | — | WO | claimed |
| WO-2023235807-A2 | METHOD AND COMPOSITIONS FOR TREATING GLIOBLASTOMA WITH TRITERPENES | PHOENIX BIOTECHNOLOGY, INC. (US) | 2023-12-07 | — | — | WO | claimed |
| US-11806359-B2 | Method and compositions for treating Coronavirus infection | PHOENIX BIOTECHNOLOGY, INC. (US) | 2023-11-07 | — | — | US | claimed |
| US-20230158093-A1 | Extract containing oleandrin and method of production thereof | PHOENIX BIOTECHNOLOGY, INC. (US) | 2023-05-25 | — | — | US | claimed |
| WO-2023022866-A1 | METHOD AND COMPOSITIONS FOR TREATING ANIMAL VIRAL INFECTIONS | PHOENIX BIOTECHNOLOGY, INC. (US) | 2023-02-23 | — | — | WO | claimed |
| JP-2921989-B2 | — | — | 1999-07-19 | — | — | JP | claimed |
| US-5804371-A | HAPTEN-ACTIVE ESTER DERIVATIVE IS COUPLED TO A FREE PRIMARY AMINO GROUP OF THE PEPTIDE | BOEHRINGER MANNHEIM GMBH (DE) | 1998-09-08 | — | — | US | claimed |
| CN-1130910-A | Hapten-labelled peptides | BOEHRINGER MANNHEIM GMBH (DE) | 1996-09-11 | — | — | CN | claimed |
| EP-0723551-A1 | HAPTEN-MARKED PEPTIDES | Roche Diagnostics GmbH (DE) | 1996-07-31 | — | — | EP | claimed |
| WO-1996003423-A9 | HAPTEN-MARKED PEPTIDES | — | 1996-03-07 | — | — | WO | claimed |
| WO-1996003423-A1 | HAPTEN-MARKED PEPTIDES | BOEHRINGER MANNHEIM GMBH (DE) | 1996-02-08 | — | — | WO | claimed |
| EP-0341745-B1 | Crosslinked carboxy polysaccharides | FIDIA SPA (IT) | 1994-12-14 | — | — | EP | claimed |
| EP-0614914-A2 | Crosslinked carboxy polysaccharides | FIDIA S.p.A. (IT) | 1994-09-14 | — | — | EP | claimed |
| US-4011212-A | 22-CYANO-24-NORCHOLANES | AMERICAN HOME PRODUCTS CORPORATION (US) | 1977-03-08 | — | — | US | claimed |
| US-3944541-A | 22-Cyano-24-norcholanes | AMERICAN HOME PRODUCTS CORPORATION (US) | 1976-03-16 | — | — | US | claimed |